Literature DB >> 24522186

Oncogenic K-Ras suppresses IP₃-dependent Ca²⁺ release through remodelling of the isoform composition of IP₃Rs and ER luminal Ca²⁺ levels in colorectal cancer cell lines.

Cristina Pierro1, Simon J Cook, Thomas C F Foets, Martin D Bootman, H Llewelyn Roderick.   

Abstract

The GTPase Ras is a molecular switch engaged downstream of G-protein-coupled receptors and receptor tyrosine kinases that controls multiple cell-fate-determining signalling pathways. Ras signalling is frequently deregulated in cancer, underlying associated changes in cell phenotype. Although Ca(2+) signalling pathways control some overlapping functions with Ras, and altered Ca(2+) signalling pathways are emerging as important players in oncogenic transformation, how Ca(2+) signalling is remodelled during transformation and whether it has a causal role remains unclear. We have investigated Ca(2+) signalling in two human colorectal cancer cell lines and their isogenic derivatives in which the allele encoding oncogenic K-Ras (G13D) was deleted by homologous recombination. We show that agonist-induced Ca(2+) release from the endoplasmic reticulum (ER) intracellular Ca(2+) stores is enhanced by loss of K-Ras(G13D) through an increase in the Ca(2+) content of the ER store and a modification of the abundance of inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) subtypes. Consistently, uptake of Ca(2+) into mitochondria and sensitivity to apoptosis was enhanced as a result of K-Ras(G13D) loss. These results suggest that suppression of Ca(2+) signalling is a common response to naturally occurring levels of K-Ras(G13D), and that this contributes to a survival advantage during oncogenic transformation.

Entities:  

Keywords:  Ca2+, Mitochondria; Cancer; IP3; Inositol 1,4,5-trisphosphate; K-Ras

Mesh:

Substances:

Year:  2014        PMID: 24522186     DOI: 10.1242/jcs.141408

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  34 in total

Review 1.  Crosstalk between calcium and reactive oxygen species signaling in cancer.

Authors:  Nadine Hempel; Mohamed Trebak
Journal:  Cell Calcium       Date:  2017-01-18       Impact factor: 6.817

2.  Electrophysiology-based stratification of pancreatic tumorigenicity by label-free single-cell impedance cytometry.

Authors:  J S McGrath; C Honrado; J H Moore; S J Adair; W B Varhue; A Salahi; V Farmehini; B J Goudreau; S Nagdas; E M Blais; T W Bauer; N S Swami
Journal:  Anal Chim Acta       Date:  2019-12-19       Impact factor: 6.558

3.  IP3 Receptor Biology and Endoplasmic Reticulum Calcium Dynamics in Cancer.

Authors:  Jan B Parys; Geert Bultynck; Tim Vervliet
Journal:  Prog Mol Subcell Biol       Date:  2021

4.  [Pt(O,O'-acac)(γ-acac)(DMS)]: Alternative Strategies to Overcome Cisplatin-Induced Side Effects and Resistance in T98G Glioma Cells.

Authors:  Valentina Astesana; Pawan Faris; Beatrice Ferrari; Stella Siciliani; Dmitry Lim; Marco Biggiogera; Sandra Angelica De Pascali; Francesco Paolo Fanizzi; Elisa Roda; Francesco Moccia; Maria Grazia Bottone
Journal:  Cell Mol Neurobiol       Date:  2020-05-19       Impact factor: 5.046

Review 5.  The Calcium-Signaling Toolkit in Cancer: Remodeling and Targeting.

Authors:  Sarah J Roberts-Thomson; Silke B Chalmers; Gregory R Monteith
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

Review 6.  The calcium-cancer signalling nexus.

Authors:  Gregory R Monteith; Natalia Prevarskaya; Sarah J Roberts-Thomson
Journal:  Nat Rev Cancer       Date:  2017-04-07       Impact factor: 60.716

7.  TCGA database analysis of the tumor mutation burden and its clinical significance in colon cancer.

Authors:  Junjie Chen; Anwaier Apizi; Lin Wang; Guanting Wu; Zheng Zhu; Huihui Yao; Guoliang Chen; Xinyu Shi; Bo Shi; Qingliang Tai; Chenglong Shen; Guoqiang Zhou; Lingzhi Wu; Songbing He
Journal:  J Gastrointest Oncol       Date:  2021-10

Review 8.  The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca²⁺-release channel.

Authors:  Tamara Vervloessem; David I Yule; Geert Bultynck; Jan B Parys
Journal:  Biochim Biophys Acta       Date:  2014-12-10

9.  Oncogenic KRAS suppresses store-operated Ca2+ entry and ICRAC through ERK pathway-dependent remodelling of STIM expression in colorectal cancer cell lines.

Authors:  Cristina Pierro; Xuexin Zhang; Cynthia Kankeu; Mohamed Trebak; Martin D Bootman; H Llewelyn Roderick
Journal:  Cell Calcium       Date:  2018-03-14       Impact factor: 6.817

Review 10.  How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

Authors:  Christian Stock
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.